New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
Non-alcoholic fatty liver disease (NAFLD) has become a major chronic disease in contemporary society, affected by N6-methyladenosine (m6A) RNA methylation, one of the most common RNA modifications. Compared with healthy control, m6A RNA methyltransferase 3 (METTL3) and METTL14 increased, while Wilms...
Main Authors: | Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Susu Yu, Xinyue Peng, Wenji Zhang, Wenjuan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.973116/full |
Similar Items
-
The role of N6-methyladenosine in macrophage polarization: A novel treatment strategy for non-alcoholic steatohepatitis
by: Jiaxuan Wu, et al.
Published: (2024-02-01) -
Roles of N6‐methyladenosine epitranscriptome in non‐alcoholic fatty liver disease and hepatocellular carcinoma
by: Yuyan Chen, et al.
Published: (2023-08-01) -
Epigenetic regulation of N6‐methyladenosine modifications in obesity
by: Mingli Sun, et al.
Published: (2021-08-01) -
N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC
by: Tan C, et al.
Published: (2023-09-01) -
Insights into the role of N6-methyladenosine in ferroptosis
by: Jingyuan Zhang, et al.
Published: (2023-09-01)